Skip to main content
PMC home page
Health Services Research logoLink to Health Services Research
. 2000 Jun;35(2):389–416.

Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

R Andersen 1, S Bozzette 1, M Shapiro 1, P St Clair 1, S Morton 1, S Crystal 1, D Goldman 1, N Wenger 1, A Gifford 1, A Leibowitz 1, S Asch 1, S Berry 1, T Nakazono 1, K Heslin 1, W Cunningham 1
PMCID: PMC1089126  PMID: 10857469

Abstract

OBJECTIVE: To employ the behavioral model of health services use in examining the extent to which predisposing, enabling, and need factors explain the treatment of the HIV-positive population in the United States with highly active antiretroviral therapy (HAART). DATA SOURCE: A national probability sample of 2,776 adults under treatment for human immunodeficiency virus (HIV) infection. STUDY DESIGN: The article uses data from the baseline and six-month follow-up surveys. The key independent variables describe vulnerable population groups including women, drug users, ethnic minorities, and the less educated. The dependent variable is whether or not a respondent received HAART by December 1996. DATA COLLECTION: All interviews were conducted using computer-assisted personal interview instruments designed for this study. Ninety-two percent of the baseline interviews were conducted in person and the remainder over the telephone. PRINCIPAL FINDINGS: A multistage logit regression shows that the predisposing factors that have previously described vulnerable groups in the general population with limited access to medical care also define HIV-positive groups who are less likely to gain early access to HAART including women, injection drug users, African Americans, and the least educated (odds ratios, controlling for need, ranged from 0.35 to 0.59). CONCLUSIONS: Those HIV-positive persons with the greatest need (defined by a low CD4 count) are most likely to have early access to HAART, which suggests equitable access. However, some predisposing and enabling variables continue to be important as well, suggesting inequitable access, especially for African Americans and lower-income groups. Policymakers and clinicians need to be sensitized to the continued problems of African Americans and other vulnerable populations in gaining access to such potentially beneficial therapies. Higher income, anonymous test sites, and same-day appointments are important enabling resources.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aday L. A., Lee E. S., Spears B., Chung C. W., Youssef A., Bloom B. Health insurance and utilization of medical care for children with special health care needs. Med Care. 1993 Nov;31(11):1013–1026. doi: 10.1097/00005650-199311000-00004. [DOI] [PubMed] [Google Scholar]
  2. Andersen R. M., McCutcheon A., Aday L. A., Chiu G. Y., Bell R. Exploring dimensions of access to medical care. Health Serv Res. 1983 Spring;18(1):49–74. [PMC free article] [PubMed] [Google Scholar]
  3. Andersen R. M. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995 Mar;36(1):1–10. [PubMed] [Google Scholar]
  4. Andrulis D. P., Weslowski V. B., Hintz E., Spolarich A. W. Comparisons of hospital care for patients with AIDS and other HIV-related conditions. JAMA. 1992 May 13;267(18):2482–2486. [PubMed] [Google Scholar]
  5. Bindman A. B., Osmond D., Hecht F. M., Lehman J. S., Vranizan K., Keane D., Reingold A. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA. 1998 Oct 28;280(16):1416–1420. doi: 10.1001/jama.280.16.1416. [DOI] [PubMed] [Google Scholar]
  6. Blendon R. J., Aiken L. H., Freeman H. E., Corey C. R. Access to medical care for black and white Americans. A matter of continuing concern. JAMA. 1989 Jan 13;261(2):278–281. [PubMed] [Google Scholar]
  7. Bozzette S. A., Berry S. H., Duan N., Frankel M. R., Leibowitz A. A., Lefkowitz D., Emmons C. A., Senterfitt J. W., Berk M. L., Morton S. C. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998 Dec 24;339(26):1897–1904. doi: 10.1056/NEJM199812243392606. [DOI] [PubMed] [Google Scholar]
  8. Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Saag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998 Jul 1;280(1):78–86. doi: 10.1001/jama.280.1.78. [DOI] [PubMed] [Google Scholar]
  9. Crystal S., Sambamoorthi U., Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995 Oct;30(4):593–614. [PMC free article] [PubMed] [Google Scholar]
  10. Cunningham W. E., Hays R. D., Ettl M. K., Dixon W. J., Liu R. C., Beck C. K., Shapiro M. F. The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease. Med Care. 1998 Mar;36(3):295–306. doi: 10.1097/00005650-199803000-00007. [DOI] [PubMed] [Google Scholar]
  11. Curtis J. R., Patrick D. L. Race and survival time with AIDS: a synthesis of the literature. Am J Public Health. 1993 Oct;83(10):1425–1428. doi: 10.2105/ajph.83.10.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Easterbrook P. J., Keruly J. C., Creagh-Kirk T., Richman D. D., Chaisson R. E., Moore R. D. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA. 1991 Nov 20;266(19):2713–2718. [PubMed] [Google Scholar]
  13. Fleishmann J. A., Mor V., Laliberte L. L. Longitudinal patterns of medical service use and costs among people with AIDS. Health Serv Res. 1995 Aug;30(3):403–424. [PMC free article] [PubMed] [Google Scholar]
  14. Frankel M. R., Shapiro M. F., Duan N., Morton S. C., Berry S. H., Brown J. A., Burnam M. A., Cohn S. E., Goldman D. P., McCaffrey D. F. National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Serv Res. 1999 Dec;34(5 Pt 1):969–992. [PMC free article] [PubMed] [Google Scholar]
  15. Freeman H. E., Blendon R. J., Aiken L. H., Sudman S., Mullinix C. F., Corey C. R. Americans report on their access to health care. Health Aff (Millwood) 1987 Spring;6(1):6–8. doi: 10.1377/hlthaff.6.1.6. [DOI] [PubMed] [Google Scholar]
  16. Hayward R. A., Shapiro M. F., Freeman H. E., Corey C. R. Inequities in health services among insured Americans. Do working-age adults have less access to medical care than the elderly? N Engl J Med. 1988 Jun 9;318(23):1507–1512. doi: 10.1056/NEJM198806093182305. [DOI] [PubMed] [Google Scholar]
  17. Lemp G. F., Hirozawa A. M., Cohen J. B., Derish P. A., McKinney K. C., Hernandez S. R. Survival for women and men with AIDS. J Infect Dis. 1992 Jul;166(1):74–79. doi: 10.1093/infdis/166.1.74. [DOI] [PubMed] [Google Scholar]
  18. Mauskopf J., Turner B. J., Markson L. E., Houchens R. L., Fanning T. R., McKee L. Patterns of ambulatory care for AIDS patients, and association with emergency room use. Health Serv Res. 1994 Oct;29(4):489–510. [PMC free article] [PubMed] [Google Scholar]
  19. Moore R. D., Hidalgo J., Sugland B. W., Chaisson R. E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 16;324(20):1412–1416. doi: 10.1056/NEJM199105163242006. [DOI] [PubMed] [Google Scholar]
  20. Moore R. D., Stanton D., Gopalan R., Chaisson R. E. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994 Mar 17;330(11):763–768. doi: 10.1056/NEJM199403173301107. [DOI] [PubMed] [Google Scholar]
  21. Mor V., Fleishman J. A., Dresser M., Piette J. Variation in health service use among HIV-infected patients. Med Care. 1992 Jan;30(1):17–29. doi: 10.1097/00005650-199201000-00002. [DOI] [PubMed] [Google Scholar]
  22. Nakashima A. K., Horsley R., Frey R. L., Sweeney P. A., Weber J. T., Fleming P. L. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA. 1998 Oct 28;280(16):1421–1426. doi: 10.1001/jama.280.16.1421. [DOI] [PubMed] [Google Scholar]
  23. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  24. Phillips K. A., Morrison K. R., Andersen R., Aday L. A. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res. 1998 Aug;33(3 Pt 1):571–596. [PMC free article] [PubMed] [Google Scholar]
  25. Shapiro M. F., Morton S. C., McCaffrey D. F., Senterfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999 Jun 23;281(24):2305–2315. doi: 10.1001/jama.281.24.2305. [DOI] [PubMed] [Google Scholar]
  26. Stein M. D., Mor V. The use of multiple physicians among symptomatic HIV-positive persons. Med Care. 1993 Oct;31(10):968–974. doi: 10.1097/00005650-199310000-00008. [DOI] [PubMed] [Google Scholar]
  27. Stein M. D., Piette J., Mor V., Wachtel T. J., Fleishman J., Mayer K. H., Carpenter C. C. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991 Jan-Feb;6(1):35–40. doi: 10.1007/BF02599388. [DOI] [PubMed] [Google Scholar]
  28. Turner B. J., McKee L., Fanning T., Markson L. E. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Med Care. 1994 Sep;32(9):902–916. doi: 10.1097/00005650-199409000-00002. [DOI] [PubMed] [Google Scholar]
  29. Zucconi S. L., Jacobson L. P., Schrager L. K., Kass N. E., Lave J. R., Carson C. A., Morgenstern H., Arno P. S., Graham N. M. Impact of immunosuppression on health care use by men in the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr. 1994 Jun;7(6):607–616. [PubMed] [Google Scholar]

Articles from Health Services Research are provided here courtesy of Health Research & Educational Trust

RESOURCES